By demonstrating a corporate responsibility towards society we hope to show the true value of our company.
Initial estimate shows that, in China, there are two million ESRD(end-stage renal disease)patients，with an increase of 15%，who need regular kidney dialysis treatment. As you might imagine, the global data must be much bigger. For hemodialysis, patients need treatment 2-3 times a week, 4 to 4.5 hours each time. This has led us to create innovative products that provide benefits to every patients around the world. Zirconium phosphate we developed for automated wearable artificial kidney, as a new material, will reduce the treatment cost as a whole, make more patients get effective treatment at home.
Contribution to technologies for patients world wide with zirconium phosphates and other relevant products. That`s our mission.
